These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7378994)

  • 1. Role of serum carcinoembryonic antigen in preoperative diagnosis of cancer in patients with thyroid nodules.
    Madeddu G; Langer M; Dettori G; Costanza C
    Cancer; 1980 May; 45(10):2607-10. PubMed ID: 7378994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of medullary carcinoma of the thyroid with carcinoembryonic antigen.
    Ishikawa N; Hamada S
    Br J Cancer; 1976 Aug; 34(2):111-5. PubMed ID: 962990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen in thyroid disease.
    Economidou J; Karacoulis P; Manousos ON; Manesis E; Kydonakis A; Koutras DA
    J Clin Pathol; 1977 Sep; 30(9):878-80. PubMed ID: 915016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.
    Hamada S; Ishikawa N; Yoshi M; Morita R; Fukunaga M
    Endocrinol Jpn; 1976 Dec; 23(6):505-10. PubMed ID: 1022524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies.
    Schröder S; Klöppel G
    Am J Surg Pathol; 1987 Feb; 11(2):100-8. PubMed ID: 2433953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
    Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
    Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
    Calmettes C; Moukhtar MS; Milhaud G
    Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
    Saad MF; Fritsche HA; Samaan NA
    J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
    Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
    Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
    Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of carcinoembryonic antigen in medullary thyroid carcinoma by immunofluorescent techniques.
    Hamada S; Hamada S
    Br J Cancer; 1977 Nov; 36(5):572-6. PubMed ID: 337999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tissue polypeptide antigen (TPA) in thyroid cancer.
    Martino E; Bambini G; Aghini-Lombardi F; Motz E; Pacini F; Lari R; Baschieri L; Pinchera A
    J Endocrinol Invest; 1984 Jun; 7(3):249-52. PubMed ID: 6547969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen fraction in digestive cancer.
    Fong S; García Vega G; León V
    Neoplasma; 1985; 32(2):199-208. PubMed ID: 4000309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
    Palmer BV; Harmer CL; Shaw HJ
    Br J Surg; 1984 Feb; 71(2):101-4. PubMed ID: 6692098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the diagnosis and treatment of medullary thyroid carcinoma.
    Brunt LM; Wells SA
    Surg Clin North Am; 1987 Apr; 67(2):263-79. PubMed ID: 2882613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
    Chen SW; Chen YK
    World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
    Machens A; Ukkat J; Hauptmann S; Dralle H
    Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising CEA levels in a patient with colon carcinoma: metachronous medullary thyroid cancer.
    Göksu SS; Göksu UA; Gündüz S; Coskun HS
    Int J Biol Markers; 2014 Jun; 29(2):e184-6. PubMed ID: 24425322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.